Diabetes mellitus induced inhibition of glucosaminyl N-deacetylase: effect of short-term blood glucose control in diabetic rats
- PMID: 8477875
- DOI: 10.1007/BF00400233
Diabetes mellitus induced inhibition of glucosaminyl N-deacetylase: effect of short-term blood glucose control in diabetic rats
Abstract
Inhibition of glucosaminyl N-deacetylase activity, a key enzyme in heparan sulphate sulphation, may be involved in the development of late diabetic vascular complications. We examined the effect of short- and long-term metabolic control on N-deacetylase activity in streptozotocin diabetic H and U rats. Spontaneously diabetic BB rats were included in parts of the study. Over a 3-week period blood glucose was maintained at predetermined levels (6-10 mmol/l or 10-20 mmol/l) by insulin treatment and then during the final 2 days rapidly reversed in half of each group. In the U rats, the hepatic N-deacetylase activity significantly decreased by 10-15% following short- and long-term poor metabolic control and the inhibition was entirely reversed by short-term good control. In the H rats a similar, not significant, effect was seen. BB rats in long-term poor control showed a 10% reduction in hepatic N-deacetylase activity (p = 0.003). Glomerular N-deacetylase activity was reduced in U rats after long-term poor control (p = 0.004) but not in H and BB rats. There was an overall correlation between urinary albumin excretion and glomerular N-deacetylase activity (r = -0.60, p < 0.0001). We conclude that diabetes-induced inhibition of hepatic N-deacetylase is not restricted to the streptozotocin diabetic model, and that short-term blood glucose control is of major importance. Genetic factors and tissue specificity influence the vulnerability of the enzyme. Finally, the study suggests an association between N-deacetylase activity and urinary albumin excretion.
Similar articles
-
Inhibition of glomerular glucosaminyl N-deacetylase in diabetic rats.Kidney Int. 1992 Apr;41(4):763-7. doi: 10.1038/ki.1992.119. Kidney Int. 1992. PMID: 1513099
-
Glucosaminyl N-deacetylase mRNA expression in diabetic rats.Exp Clin Endocrinol Diabetes. 1999;107(7):453-6. doi: 10.1055/s-0029-1212137. Exp Clin Endocrinol Diabetes. 1999. PMID: 10595597
-
Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C.Diabetes. 2000 Jan;49(1):87-93. doi: 10.2337/diabetes.49.1.87. Diabetes. 2000. PMID: 10615954
-
Glomerular metalloprotease activity in streptozotocin- treated rats and in spontaneously diabetic rats (BB/DP).Life Sci. 1994;55(12):941-50. doi: 10.1016/0024-3205(94)00540-0. Life Sci. 1994. PMID: 8057756
-
Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels.Prostaglandins Other Lipid Mediat. 2017 Sep;132:3-11. doi: 10.1016/j.prostaglandins.2016.08.004. Epub 2016 Sep 3. Prostaglandins Other Lipid Mediat. 2017. PMID: 27596333 Review.
Cited by
-
N-sulfation of heparan sulfate is critical for syndecan-4-mediated podocyte cell-matrix interactions.Am J Physiol Renal Physiol. 2016 May 15;310(10):F1123-35. doi: 10.1152/ajprenal.00603.2015. Epub 2016 Mar 2. Am J Physiol Renal Physiol. 2016. PMID: 26936875 Free PMC article.
-
Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice.J Clin Invest. 2000 Jun;105(12):1807-18. doi: 10.1172/JCI8283. J Clin Invest. 2000. PMID: 10862796 Free PMC article.
-
Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy.Diabetologia. 1995 Oct;38(10):1169-75. doi: 10.1007/BF00422365. Diabetologia. 1995. PMID: 8690168
-
Glucosaminyl N-deacetylase in cultured fibroblasts; comparison of patients with and without diabetic nephropathy, and identification of a possible mechanism for diabetes-induced N-deacetylase inhibition.Diabetologia. 1993 Jun;36(6):536-40. doi: 10.1007/BF02743270. Diabetologia. 1993. PMID: 8335176
-
Increased Urine IgM and IgG(2) Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes.Biochem Res Int. 2012;2012:480529. doi: 10.1155/2012/480529. Epub 2012 Feb 12. Biochem Res Int. 2012. PMID: 22400116 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical